HMGB1 and cancer: Hence, HMGB1-necroptosis axis critically impact the therapeutic outcomes, where the initial inflammatory signal triggered by HMGB1 release can be subverted to support tumor survival, immune evasion, and treatment resistance across several cancer types (Figure 3).